No. 25A806
Pharmaceutical Research and Manufacturers of America v. Sean O'Day, in His Official Capacity as Director of the Oregon Department of Consumer and Business Services
Tags: compelled-speech first-amendment intermediate-scrutiny pharmaceutical-regulation takings-clause trade-secrets
Key Terms:
FirstAmendment Takings TradeSecret
FirstAmendment Takings TradeSecret
Latest Conference:
N/A
Question Presented (from Petition)
Question not identified.
Question Presented (AI Summary)
Whether a state law requiring pharmaceutical manufacturers to disclose confidential trade secrets and create narrative justifications for drug pricing violates the First Amendment's protection against compelled speech and the Takings Clause's prohibition on uncompensated property seizures
Docket Entries
2026-01-12
Application (25A806) granted by Justice Kagan extending the time to file until February 20, 2026.
2026-01-08
Application (25A806) to extend the time to file a petition for a writ of certiorari from January 21, 2026 to February 20, 2026, submitted to Justice Kagan.
Attorneys
Pharmaceutical Research and Manufacturers of America
Allon Kedem — Arnold & Porter Kaye Scholer LLP, Petitioner